Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1979 Oct;26(1):235–239. doi: 10.1128/iai.26.1.235-239.1979

Effect of cholera toxin on the antiviral and anticellular activities of human leukocyte interferon.

A Fuse, T Kuwata
PMCID: PMC414601  PMID: 227795

Abstract

Cholera toxin added into cell cultures together with human leukocyte interferon inhibited the establishment of the antiviral state by interferon but not the anticellular activity of interferon in human cells. Sensitivities of various human cell lines to anticellular activities of interferon and cholera toxin were compared, but no direct correlation between both activities were demonstrated. These results suggest that antiviral and anticellular activities of interferon are due to different mechanism of actions, and cholera toxin does not act directly on the receptor site for interferon.

Full text

PDF
235

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Besancon F., Ankel H., Basu S. Specificity and reversibility of interferon ganglioside interaction. Nature. 1976 Feb 19;259(5544):576–578. doi: 10.1038/259576a0. [DOI] [PubMed] [Google Scholar]
  2. Besancon F., Ankel H. Binding of interferon to gangliosides. Nature. 1974 Dec 6;252(5483):478–480. doi: 10.1038/252478a0. [DOI] [PubMed] [Google Scholar]
  3. Dahl H., Degre M. Separation of antiviral activity of human interferon from cell growth inhibitory effect. Nature. 1975 Oct 30;257(5529):799–800. doi: 10.1038/257799a0. [DOI] [PubMed] [Google Scholar]
  4. De Clercq E., Edy V. G., Cassiman J. Non-antiviral activities of interferon are not controlled by chromosome 21. Nature. 1975 Jul 10;256(5513):132–134. doi: 10.1038/256132a0. [DOI] [PubMed] [Google Scholar]
  5. Degré M. Cholera toxin inhibits antiviral and growth inhibitory activities of human interferon. Proc Soc Exp Biol Med. 1978 Feb;157(2):253–255. [PubMed] [Google Scholar]
  6. Friedman R. B. The mechanism of action of interferon: possible primary effects on membranes. Horiz Biochem Biophys. 1978;5:281–313. [PubMed] [Google Scholar]
  7. Friedman R. M. Antiviral activity of interferons. Bacteriol Rev. 1977 Sep;41(3):543–567. doi: 10.1128/br.41.3.543-567.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Friedman R. M., Grollman E. F., Chang E. H., Kohn L. D., Lee G., Jay F. T. Interferon and glycoprotein hormones. Tex Rep Biol Med. 1977;35:326–329. [PubMed] [Google Scholar]
  9. Friedman R. M., Kohn L. D. Cholera toxin inhibits interferon action. Biochem Biophys Res Commun. 1976 Jun 21;70(4):1078–1084. doi: 10.1016/0006-291x(76)91012-3. [DOI] [PubMed] [Google Scholar]
  10. Fuse A., Kuwata T. Effects of interferon on the human clonal cell line, RSa: inhibition of macromolecular synthesis. J Gen Virol. 1976 Oct;33(1):17–24. doi: 10.1099/0022-1317-33-1-17. [DOI] [PubMed] [Google Scholar]
  11. Fuse A., Kuwata T. Inhibition of DNA synthesis and alteration of cyclic adenosine 3',5'-monophosphate levels in RSa cells by human leukocyte interferon. J Natl Cancer Inst. 1978 Jun;60(6):1227–1232. doi: 10.1093/jnci/60.6.1227. [DOI] [PubMed] [Google Scholar]
  12. Fuse A., Kuwata T. Inhibition of DNA synthesis of synchronized RSa cells by human leukocyte interferon. J Natl Cancer Inst. 1977 Apr;58(4):891–896. doi: 10.1093/jnci/58.4.891. [DOI] [PubMed] [Google Scholar]
  13. Fuse T. K., Morinaga N. Effects of interferon on cell and virus growth in transformed human cell lines. J Gen Virol. 1976 Oct;33(1):7–15. doi: 10.1099/0022-1317-33-1-7. [DOI] [PubMed] [Google Scholar]
  14. Hollenberg M. D., Fishman P. H., Bennett V., Cuatrecasas P. Cholera toxin and cell growth: role of membrane gangliosides. Proc Natl Acad Sci U S A. 1974 Oct;71(10):4224–4228. doi: 10.1073/pnas.71.10.4224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Holmgren J., Lindholm L. Cholera toxin, ganglioside receptors and the immune response. Immunol Commun. 1976;5(9):737–756. doi: 10.3109/08820137609047617. [DOI] [PubMed] [Google Scholar]
  16. Honma M., Satoh T., Takezawa J., Ui M. An ultrasensitive method for the simultaneous determination of cyclic AMP and cyclic GMP in small-volume samples from blood and tissue. Biochem Med. 1977 Dec;18(3):257–273. doi: 10.1016/0006-2944(77)90060-6. [DOI] [PubMed] [Google Scholar]
  17. Iwakura Y., Yonehara S., Kawade Y. Purification of mouse L cell interferon. Essentially pure preparations with associated cell growth inhibitory activity. J Biol Chem. 1978 Jul 25;253(14):5074–5079. [PubMed] [Google Scholar]
  18. Kading V. H., Blalock J. E., Gifford G. E. Effect of serum on the antiviral and anticellular activities of mouse interferon. Arch Virol. 1978;56(3):237–242. doi: 10.1007/BF01317852. [DOI] [PubMed] [Google Scholar]
  19. Kawakita M., Cabrer B., Taira H., Rebello M., Slattery E., Weideli H., Lengyel P. Purification of interferon from mouse Ehrlich ascites tumor cells. J Biol Chem. 1978 Jan 25;253(2):598–602. [PubMed] [Google Scholar]
  20. Kohn L. D., Friedman R. M., Holmes J. M., Lee G. Use of thyrotropin and cholera toxin to probe the mechanism by which interferon initiates its antiviral activity. Proc Natl Acad Sci U S A. 1976 Oct;73(10):3695–3699. doi: 10.1073/pnas.73.10.3695. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kuwata T., Fuse A., Morinaga N. Effects of cycloheximide and puromycin on the antiviral and anticellular activities of human interferon. J Gen Virol. 1977 Oct;37(1):195–198. doi: 10.1099/0022-1317-37-1-195. [DOI] [PubMed] [Google Scholar]
  22. Kuwata T., Fuse A., Morinaga N. Effects of ouabain on the anticellular and antiviral activities of human and mouse interferon. J Gen Virol. 1977 Mar;34(3):537–540. doi: 10.1099/0022-1317-34-3-537. [DOI] [PubMed] [Google Scholar]
  23. Kuwata T., Handa S., Fuse A., Morinaga N. Effect of glycolipids detectable in transformed human cells on interferon activities. Biochem Biophys Res Commun. 1978 Nov 14;85(1):77–84. doi: 10.1016/s0006-291x(78)80013-8. [DOI] [PubMed] [Google Scholar]
  24. Kuwata T., Oda T., Sekiya S., Morinaga N. Characteristics of a human cell line successively transformed by Rous sarcoma virus and simian virus 40. J Natl Cancer Inst. 1976 May;56(5):919–926. doi: 10.1093/jnci/56.5.919. [DOI] [PubMed] [Google Scholar]
  25. Meldolesi M. F., Friedman R. M., Kohn L. D. An interferon-induced increase in cyclic AMP levels precedes the establishment of the antiviral state. Biochem Biophys Res Commun. 1977 Nov 7;79(1):239–246. doi: 10.1016/0006-291x(77)90086-9. [DOI] [PubMed] [Google Scholar]
  26. Moehring T. J., Moehring J. M., Stinebring W. R. Response of interferon-treated cells to diphtheria toxin. Infect Immun. 1971 Dec;4(6):747–752. doi: 10.1128/iai.4.6.747-752.1971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Mullin B. R., Aloj S. M., Fishman P. H., Lee G., Kohn L. D., Brady R. O. Cholera toxin interactions with thyrotropin receptors on thyroid plasma membranes. Proc Natl Acad Sci U S A. 1976 May;73(5):1679–1683. doi: 10.1073/pnas.73.5.1679. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tomita Y., Kuwata T. Suppressive effects of interferon on syncytium formation by RD-114 virus in human transformed cells. J Gen Virol. 1979 Apr;43(1):111–117. doi: 10.1099/0022-1317-43-1-111. [DOI] [PubMed] [Google Scholar]
  29. Vengris V. E., Reynolds F. H., Jr, Hollenberg M. D., Pitha P. M. Interferon action: role of membrane gangliosides. Virology. 1976 Jul 15;72(2):486–493. doi: 10.1016/0042-6822(76)90177-x. [DOI] [PubMed] [Google Scholar]
  30. Weber J. M., Stewart R. B. Cyclic AMP potentiation of interferon antiviral activity and effect of interferon on cellular cyclic AMP levels. J Gen Virol. 1975 Sep;28(3):363–372. doi: 10.1099/0022-1317-28-3-363. [DOI] [PubMed] [Google Scholar]
  31. van Heyningen S. Cholera toxin. Biol Rev Camb Philos Soc. 1977 Nov;52(4):509–509. doi: 10.1111/j.1469-185x.1977.tb00858.x. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES